相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II
Christine E. Staatz et al.
CLINICAL PHARMACOKINETICS (2010)
Enantioselective Determination of Ondansetron and 8-Hydroxyondansetron in Human Plasma from Recovered Surgery Patients by Liquid Chromatography-Tandem Mass Spectrometry
F. Musshoff et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2010)
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part I
Shu-Feng Zhou
CLINICAL PHARMACOKINETICS (2009)
Impact of CYP3A5 and CYP3A4 gene polymorphisms on dose requirement of calcineurin inhibitors, cyclosporine and tacrolimus, in renal allograft recipients of North India
Ranjana Singh et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Quantitative determination of ondansetron in human plasma by enantioselective liquid chromatography-tandem mass spectrometry
Ke Liu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
CYP3A7, CYP3A5, CYP3A4, and ABCB1 Genetic Polymorphisms, Cyclosporine Concentration, and Dose Requirement in Transplant Recipients
Severine Crettol et al.
THERAPEUTIC DRUG MONITORING (2008)
The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype
A. Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
Magnus Ingelman-Sundberg et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas
Cristina Rodriguez-Antona et al.
BLOOD (2007)
Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes
U. M. Stamer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers
Rasmus Steen Pedersen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Clinical implications of CYP3A polymorphisms
Leszek Wojnowski et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles
C Rodríguez-Antona et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Cyp3A5 genetic polymorphisms in different ethnic populations
JN Roy et al.
DRUG METABOLISM AND DISPOSITION (2005)
5-HT3-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment
M Aapro
ONCOLOGY (2005)
Genetics of the variable expression of CYP3A in humans
L Wojnowski
THERAPEUTIC DRUG MONITORING (2004)
Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic-polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes
DA Hesselink et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting
CC Apfel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Impact of CYP2D6 genotype on postoperative tramadol analgesia
UM Stamer et al.
PAIN (2003)
Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus
DA Hesselink et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Consensus guidelines for managing postoperative nausea and vomiting
TJ Gan et al.
ANESTHESIA AND ANALGESIA (2003)
Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes
R Kaiser et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
The genetic determinants of the CYP3A5 polymorphism
E Hustert et al.
PHARMACOGENETICS (2001)
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl et al.
NATURE GENETICS (2001)
分享论文
